These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11579840)

  • 1. [Calcium channel blockers in the treatment of cardiovascular disease].
    Halawa B
    Pol Merkur Lekarski; 2001 Jul; 11(61):83-7. PubMed ID: 11579840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differential therapy with calcium antagonists].
    Scholze JE
    Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-channel blockers and the elderly.
    Ryan C
    Compr Ther; 1990 Jun; 16(6):51-4. PubMed ID: 2373003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clinical pharmacology of calcium channel blockers.
    Kim KE
    Am Fam Physician; 1991 Feb; 43(2):583-8. PubMed ID: 1990741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blocking drugs. Part II: Clinical applications.
    Brill DM; Fozzard HA
    Compr Ther; 1985 Oct; 11(10):67-71. PubMed ID: 2414054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients.
    Costanzo P; Perrone-Filardi P; Petretta M; Marciano C; Vassallo E; Gargiulo P; Paolillo S; Petretta A; Chiariello M
    J Hypertens; 2009 Jun; 27(6):1136-51. PubMed ID: 19451836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers in cardiovascular pharmacotherapy.
    Godfraind T
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blockers in treatment of hypertension.
    Muntwyler J; Follath F
    Prog Cardiovasc Dis; 2001; 44(3):207-16. PubMed ID: 11727278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel antagonists. What do the second-generation agents have to offer?
    Salerno SM; Zugibe FT
    Postgrad Med; 1994 Jan; 95(1):181-90. PubMed ID: 8278298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revival of nifedipine, a dihydropyridine-based calcium blocker.
    Yamagishi S; Nakamura K
    Med Hypotheses; 2007; 68(3):565-7. PubMed ID: 17011717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained-release calcium channel antagonists in cardiovascular disease: pharmacology and current therapeutic use.
    Silvestry FE; St John Sutton MG
    Eur Heart J; 1998 Aug; 19 Suppl I():I8-14. PubMed ID: 9743438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis.
    Bangalore S; Parkar S; Messerli FH
    Am J Med; 2009 Apr; 122(4):356-65. PubMed ID: 19332231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonists in the treatment of heart failure. Re-evaluation of therapeutic strategies].
    Gattis W; O'Connor CM
    Drugs; 2000; 59 Spec No 2():17-24. PubMed ID: 11002855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyridines and vascular diseases.
    Tamargo J; Delpón E
    Z Kardiol; 1991; 80 Suppl 7():106-11. PubMed ID: 1792815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M
    J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium channel blocker and cardiac hypertrophy].
    Takeda T; Otsu K; Hori M
    Clin Calcium; 2005 Oct; 15(10):1645-9. PubMed ID: 16199909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives in cardiovascular medicine: the calcium channel blocking drugs.
    Allert JA; Adams HR
    J Am Vet Med Assoc; 1987 Mar; 190(5):573-8. PubMed ID: 2435691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.